-->
Excessive ingestion of aspirin causing toxicity.
Overdose can occur as a result of deliberate self-harm, suicidal intent or by
accident (e.g. in children). Ingestion of 10–20 g can cause moderate-to-severe toxicity
in adults.
Aspirin (acetylsalicylate) increases respiratory rate and depth by stimulating the CNS respiratory
centre. This hyperventilation produces respiratory alkalosis in the early phase. The
body then compensates by increasing urinary bicarbonate and K
þ
excretion, causing
dehydration and hypokalaemia. Loss of bicarbonate together with the uncoupling of
mitochondrial oxidative phosphorylation by salicylic acid and build up of lactic acid can
lead to metabolic acidosis.
In severe overdoses, CNS depression and respiratory failure can occur.
One of the most common drug overdoses.
Ascertain the key facts:
. How much aspirin?
. When?
. Any other drugs?
. Have you had any alcohol?
The patient may be asymptomatic initially.
Early symptoms: Flushed appearance, fever, sweating, hyperventilation, dizziness, tinnitus,
deafness.
Late symptoms: Lethargy, confusion, convulsions, drowsiness, respiratory depression, coma.
Fever, tachycardia, hyperventilation, epigastric tenderness.
Blood: Salicylate levels (500–750 mg/L is a moderate overdose; >750 mg/L is a severe
overdose), FBC, U&E (particularly # K
þ
if vomiting), LFT (" AST/ALT), clotting screen
(" PT), glucose and other drug levels (e.g. paracetamol). ABG: May show mixed
metabolic acidosis and respiratory alkalosis.
ECG: May show signs of hypokalaemia – small T waves, U waves.
Acute: Resuscitate with attention to respiratory rate and blood gases. Treat hypovolaemia
(rehydrate), hypokalaemia, hypoglycaemia; vitamin K for hypoprothrombinaemia
(occasionally).
If < 12 h after ingestion: Gastric lavage to empty the stomach, and oral activated charcoal
to bind to and # absorption of the drug.
Moderate cases (500–750 mg/L): Urine alkalinization with IV NaHCO3 (with IV potassium
chloride for hypokalaemia) aims to " salicylate excretion (aim for urine pH 7.5–8.5).
Severe cases (> 750 mg/L) or in severe acidosis: Consider haemodialysis.
In all cases, monitor U&E, glucose (may " or #), temperature, pulse, respiratory rate, BP, urine
output.
Cerebral and pulmonary oedema (" capillary permeability).
Metabolic disturbances (# K
þ, # or " Na
þ, # or " glucose).
Acute renal failure.
If treated early, prognosis is good.
Note: In children < 4 years, even low doses of aspirin are associated with an increased risk of
developing Reyes syndrome (metabolic acidosis, liver and CNS disturbances). Aspirin can
also trigger an asthma attack in certain individuals.
Acute life-threatening multisystem syndrome caused by sudden release of
mast cell- and basophil-derived mediators into the circulation.
Can be classified as:
Immunologic: IgE-mediated or immune complex/complement-mediated. Non-immunologic:
mast cell or basophil degranulation without the involvement of antibodies (e.g. reactions
caused by vancomycin, codeine, ACE inhibitors).
Inflammatory mediators such as histamine, tryptase, chymase, histamine-releasing factor,
PAF, prostaglandins and leucotrienes cause bronchospasm, " capillary permeability and
# vascular tone, resulting in tissue oedema.
Common allergens include drugs (e.g. penicillin), radiological contrast agents, latex, insect
stings, egg, peanuts, shellfish and fish. Anaphylaxis may occur following repeated
administration of blood products in patients with selective IgA deficiency (as a result
of formation of anti-IgA antibodies). Anaphylaxis can also be induced by exercise.
Relatively common. Anaphylaxis occurs in 1 in 5,000 exposures to
parenteral penicillin or cephalosporins.
1–2 % of patients receiving IV radiocontrast experience a hypersensitivity reaction (often
minor). 0.5–1 % of children suffer from peanut allergy. 1 in 700 patients have selective
IgA deficiency.
Acute onset of symptoms on exposure to allergen:
. Wheeze, shortness of breath or sensation of choking.
. Swelling of lips and face.
. Pruritus, rash.
The severity of previous reactions does not predict the severity of future reactions. Patients
may have a history of other allergic hypersensitivity disorders e.g. asthma, allergic rhinitis.
Biphasic reactions occur 1–72 h after the first reaction in up to 20% of patients.
Tachypnoea, wheeze, cyanosis.
Swollen upper airways and eyes, rhinitis, conjunctival injection.
Urticarial rash (erythematous wheals).
Hypotension, tachycardia.
The diagnosis of anaphylaxis is made clinically.
Serum tryptase (measured within 15 min–3 h after onset of symptoms), or histamine levels
(measured preferably within 30 min after symptom onset) and urinary metabolites of
histamine (which may remain elevated for several hours after symptom onset) can support
the clinical diagnosis. Normal levels of these mediators do not exclude the possibility of
anaphylaxis.
After the attack:
Allergen skin testing: Identifies allergen. It should be performed by an allergy specialist,
because of the risk of anaphylaxis and the skill required for proper interpretation.
IgE immunoassays: E.g. radioallergosorbent tests (RASTs) to identify food-specific IgE in the
serum.
Stop any suspected drugs.
Resuscitation according to principles of airway, breathing and circulation.
Secure airway and give 100 % O2. Intubation and transfer to ITU may be necessary so
anaesthetist must be informed early.
Adrenaline IM (0.5 mL of 1:1,000). This can be repeated every 10 min according to response
of pulse and BP.
Antihistamine IV (10mg chlorpheniramine).
Steroids IV (100mg hydrocortisone).
Anaphylaxis (continued)
IV crystalloid or colloid to maintain blood pressure. If hypotensive, lie patient flat with head
tilted down.
Treat bronchospasm with salbutamolipratropium inhaler. Aminophylline IV infusion may
be required.
Advice: Educate on use of adrenaline pen for IM administration. Provide Medicalert bracelet.
Make note in patients notes and drug charts. Referral to an allergy specialist for
identification of the culprit allergen and education in allergen avoidance.
Respiratory failure, shock, death.
Good if prompt treatment given.
![]() |